Results 261 to 270 of about 3,094,120 (388)

Urbanicity and psychotic disorders: Facts and hypotheses. [PDF]

open access: yesDialogues Clin Neurosci, 2023
Pignon B   +4 more
europepmc   +1 more source

Safety and Effect of 12‐Month Ecopipam Treatment in Pediatric Patients with Tourette Syndrome

open access: yesMovement Disorders Clinical Practice, EarlyView.
Abstract Background Tourette syndrome (TS) is a chronic neurodevelopmental tic disorder with a considerable quality of life (QOL) burden. Objectives The goal was to determine the long‐term safety, tolerability, and clinical effects of ecopipam, a first‐in‐class dopamine D1 receptor antagonist, for TS.
Donald L. Gilbert   +7 more
wiley   +1 more source

Basic symptoms in early psychotic and depressive disorders [PDF]

open access: bronze, 2007
Frauke Schultze‐Lutter   +5 more
openalex   +1 more source

The Persistence of Dopamine Dysregulation Syndrome after Pallidal Deep Brain Stimulation in Parkinson's Disease

open access: yesMovement Disorders Clinical Practice, EarlyView.
Abstract Background Dopamine dysregulation syndrome (DDS) is a debilitating complication of Parkinson's disease (PD) dopamine replacement therapy (DRT) in which patients pathologically and/or compulsively use dopaminergic drugs to treat motor symptoms. Studies examining DDS outcomes following deep brain stimulation (DBS) are limited and have focused on
Natalie David   +3 more
wiley   +1 more source

Immune-neuroendocrine crosstalk in mood and psychotic disorders: A meta-analysis and systematic review. [PDF]

open access: yesBrain Behav Immun Health
Van Den Noortgate M   +5 more
europepmc   +1 more source

Does operational diagnosis of schizophrenia significantly impact intellectual deficits in psychotic disorders? [PDF]

open access: bronze, 2007
Hideaki Kitamura   +5 more
openalex   +1 more source

Subjective Well‐Being and Its Predictors in Parkinson's Disease and Dystonia: A Comparative Study

open access: yesMovement Disorders Clinical Practice, EarlyView.
Abstract Background Quality of life (QoL) is a commonly used outcome measure in people with chronic neurological diseases (CND). As valuable as QoL is, it does not take into account aspects of subjective well‐being (SWB) such as subjective happiness, meaning in life, life satisfaction and hope; all constructs that are considered central to well‐being ...
Suzette Shahmoon   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy